A restrictive inflow pattern does not predict implantable cardioverter-defibrillator therapy in primary prevention
- PMID: 20014210
- PMCID: PMC6653770
- DOI: 10.1002/clc.20474
A restrictive inflow pattern does not predict implantable cardioverter-defibrillator therapy in primary prevention
Abstract
Background: Current guidelines for the use of implantable cardioverter-defibrillators (ICDs) are broad and significantly increase the cost of caring for patients with heart failure. In an effort to identify the specific subset of patients who benefit from this therapy, the predictive value of numerous echocardiographic parameters have been studied. Severe diastolic dysfunction has been shown to predict adverse events in a group of patients who received an ICD for secondary prevention, but has not been tested in those who receive ICDs for primary prevention.
Hypothesis: We tested the hypothesis that a restrictive mitral inflow pattern on echocardiography will predict the risk of appropriate therapy in this patient population.
Methods: This retrospective study identified 145 consecutive patients who met primary prevention criteria for ICD implantation and had an echo performed no more than 1 year prior to receiving the ICD. A restrictive pattern was defined as a mitral inflow E/A > 2 or a deceleration time < 150 ms.
Results: A restrictive pattern was present in 69 patients (40.7% of the group). Appropriate ICD therapy occurred in 8 (11.5%) subjects with a restrictive pattern and 14 (18.4%) with a nonrestrictive pattern over 680 days of average follow-up (P = not significant). Cox regression analysis showed the presence of a restrictive pattern was not helpful in predicting time to first ICD therapy.
Conclusions: In a population of patients who received ICDs for primary prevention, echocardiographic findings of severe diastolic dysfunction were not helpful in targeting the use of ICDs to those at highest risk.
Copyright 2009 Wiley Periodicals, Inc.
Similar articles
-
Prognostic value of a restrictive mitral filling pattern in patients with systolic heart failure and an implantable cardioverter-defibrillator.Am J Cardiol. 2006 Mar 1;97(5):676-80. doi: 10.1016/j.amjcard.2005.09.114. Epub 2006 Jan 10. Am J Cardiol. 2006. PMID: 16490436
-
Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.Heart. 2013 Aug;99(16):1158-65. doi: 10.1136/heartjnl-2013-304185. Epub 2013 Jun 27. Heart. 2013. PMID: 23813845
-
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.J Am Heart Assoc. 2017 Aug 19;6(8):e006220. doi: 10.1161/JAHA.117.006220. J Am Heart Assoc. 2017. PMID: 28862957 Free PMC article.
-
Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.J Am Coll Cardiol. 2018 Oct 2;72(14):1653-1676. doi: 10.1016/j.jacc.2017.10.052. Epub 2017 Oct 30. J Am Coll Cardiol. 2018. PMID: 29097297
-
The implantable cardioverter-defibrillator: An update.Trends Cardiovasc Med. 2015 Oct;25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7. Trends Cardiovasc Med. 2015. PMID: 25912255 Review.
References
-
- Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT‐II). J Am Coll Cardiol 2004; 43: 1459–1465. - PubMed
-
- Moss AJ, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883. - PubMed
-
- Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter‐defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–237. - PubMed
-
- Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation 2006; 113: 1424–1433. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous